Envision Pharma Group
Christopher Lacek's work experience includes positions at Envision Pharma Group, Crenlo, and IBM. Christopher is currently the Vice President of Finance: FP&A at Envision Pharma Group. At Crenlo, they held the role of Director of Finance from April 2017 to January 2022 and Manager of Financial Planning Analysis from April 2016 to April 2017. Prior to that, they worked at IBM in various finance roles, including Global Lean Six Sigma and Transformation Leader, Finance from September 2014 to April 2016, Financial Planning Manager from January 2013 to September 2014, and Financial Analyst in different areas such as software revenue, software expense, and inventory and cost analysis from 2006 to 2012.
Christopher Lacek earned their Bachelor of Science (BS) degree in Finance, General from Minnesota State University, Mankato. Christopher then pursued a Master of Business Administration (MBA) degree in Business/Commerce, General at both the University of Minnesota-Duluth and the University of Minnesota-Rochester. In August 2013, they obtained a Lean Six Sigma Green Belt certification from Lean Six Sigma Master Black Belts.
This person is not in the org chart
This person is not in any offices
Envision Pharma Group
1 followers
The Envision Pharma Group is an innovative scientific communications and technology company, focused on the life science industry working with clients, authors, and the medical publishing community to develop and execute evidence-based communication programs in a transparent and compliant manner.